BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16359865)

  • 1. Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Wells GJ; Bihovsky R; Hudkins RL; Ator MA; Husten J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1151-5. PubMed ID: 16359865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors.
    Tao M; Park CH; Bihovsky R; Wells GJ; Husten J; Ator MA; Hudkins RL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):938-42. PubMed ID: 16290935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Torrisi C; Bisbocci M; Ingenito R; Ontoria JM; Rowley M; Schultz-Fademrecht C; Toniatti C; Jones P
    Bioorg Med Chem Lett; 2010 Jan; 20(2):448-52. PubMed ID: 20015648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
    Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase.
    Hattori K; Kido Y; Yamamoto H; Ishida J; Iwashita A; Mihara K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5577-81. PubMed ID: 17804225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel poly(ADP-ribose) polymerase-1 inhibitors.
    Dunn D; Husten J; Ator MA; Chatterjee S
    Bioorg Med Chem Lett; 2007 Jan; 17(2):542-5. PubMed ID: 17074482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A; Zhang J
    Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serendipitous discovery of a prodrug of a PARP-1 inhibitor.
    Dunn D; Husten J; Aimone LD; Ator MA; Chatterjee S
    Chem Biol Drug Des; 2013 Sep; 82(3):348-50. PubMed ID: 23679830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors.
    Moree WJ; Goldman P; Demaggio AJ; Christenson E; Herendeen D; Eksterowicz J; Kesicki EA; McElligott DL; Beaton G
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5126-9. PubMed ID: 18713665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient synthesis of maleimides and carbazoles via Zn(OTf)(2)-catalyzed tandem annulations of isonitriles and allenic esters.
    Li Y; Zou H; Gong J; Xiang J; Luo T; Quan J; Wang G; Yang Z
    Org Lett; 2007 Sep; 9(20):4057-60. PubMed ID: 17725362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel poly(ADP-ribose) polymerase-1 inhibitors.
    Dunn D; Husten J; Ator MA; Chatterjee S
    Bioorg Med Chem Lett; 2012 Jan; 22(1):222-4. PubMed ID: 22153339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
    Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM
    J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent.
    Zhu GD; Gandhi VB; Gong J; Thomas S; Luo Y; Liu X; Shi Y; Klinghofer V; Johnson EF; Frost D; Donawho C; Jarvis K; Bouska J; Marsh KC; Rosenberg SH; Giranda VL; Penning TD
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3955-8. PubMed ID: 18586490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.
    Andrews DM; Chaignot H; Coomber BA; Good AC; Hind SL; Johnson MR; Jones PS; Mills G; Robinson JE; Skarzynski T; Slater MJ; Somers DO
    Org Lett; 2002 Dec; 4(25):4479-82. PubMed ID: 12465917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and mixed lineage kinase activity of pyrrolocarbazole and isoindolone analogs of (+)K-252a.
    Hudkins RL; Johnson NW; Angeles TS; Gessner GW; Mallamo JP
    J Med Chem; 2007 Feb; 50(3):433-41. PubMed ID: 17266195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
    Ferraris D; Ko YS; Pahutski T; Ficco RP; Serdyuk L; Alemu C; Bradford C; Chiou T; Hoover R; Huang S; Lautar S; Liang S; Lin Q; Lu MX; Mooney M; Morgan L; Qian Y; Tran S; Williams LR; Wu QY; Zhang J; Zou Y; Kalish V
    J Med Chem; 2003 Jul; 46(14):3138-51. PubMed ID: 12825952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
    Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
    J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.